Researchers have observed that LAP exhibits the capability to facilitate the clearance of β‐amyloid protein (Aβ) and Tau protein in the Alzheimer's disease (AD) mouse model, thereby alleviating neurodegenerative lesions [25, 29]. The gene discussed is MAPT; the disease is Alzheimer disease.